PharmaEssentiaFRA:8Z1 82 Days Inventory is 209.73 as of Dec. 2025, which is 64% below its 10-year median of 584.85. GuruFocus rates FRA:8Z1 with a GF Score™ of 82/100 and a GF Value™ of €14.98. The stock has 6 warning signs investors should review. Among 919 Drug Manufacturers companies, PharmaEssentia ranks worse than 79.76% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). PharmaEssentia's Average Total Inventories for the
three
months ended in Dec. 2025 was €34.0 Mil. PharmaEssentia's Cost of Goods Sold for the
three
months ended in Dec. 2025 was €14.8 Mil.
Hence, PharmaEssentia's Days Inventory for the
three
months ended in Dec. 2025 was 209.73.
The historical rank and industry rank for PharmaEssentia's Days Inventory or its related term are showing as below:
FRA:8Z1'
s Days Inventory Range Over the Past 10 Years
Min: 272.37 Med: 584.85 Max: 8130.96
Current: 272.37
During the past 13 years, PharmaEssentia's highest Days Inventory was 8130.96. The lowest was 272.37. And the median was 584.85.
FRA:8Z1's Days Inventory is ranked worse than 79.76% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs FRA:8Z1: 272.37
PharmaEssentia's Days Inventory
declined
from Dec. 2024 (320.40) to Dec. 2025 (209.73).
Inventory Turnover measures how fast the company turns over its inventory within a year.
PharmaEssentia's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PharmaEssentia's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.26.
PharmaEssentia (FRA:8Z1) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
PharmaEssentia's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PharmaEssentia's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
PharmaEssentia Days Inventory Related Terms
PharmaEssentia Days Inventory Historical Data
* Premium members only.
The historical data trend for PharmaEssentia's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaEssentia Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's Days Inventory distribution charts can be found below:
* The bar in red indicates where PharmaEssentia's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaEssentia (FRA:8Z1) has a Days Inventory of 209.73 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PharmaEssentia and its competitors. This is 64% below median its historical median of 584.85. Over the past decade, PharmaEssentia's Days Inventory has ranged from 272.37 to 8,130.96. According to the industry distribution chart, PharmaEssentia ranks #733 out of 919 companies in the Drug Manufacturers industry, placing it in the top 79.8%.
Is PharmaEssentia's Days Inventory too high?
PharmaEssentia's current Days Inventory of 209.73 is 64% below median its 10-year median of 584.85. Over the past 10 years, this metric has ranged from a low of 272.37 to a high of 8,130.96. The Drug Manufacturers industry median Days Inventory is 164.48. PharmaEssentia's value of 209.73 is 27.5% above this industry median. Based on the distribution chart, PharmaEssentia ranks #733 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PharmaEssentia has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PharmaEssentia ranks #733 out of 919 companies for Days Inventory. This places PharmaEssentia in the lower half of its industry. The industry median Days Inventory is 164.48. PharmaEssentia's value of 209.73 is 27.5% above this benchmark. Historically, PharmaEssentia's own Days Inventory has ranged from 272.37 to 8,130.96 over the past decade. While the company's 10-year median is 584.85 vs. the industry median of 164.48, PharmaEssentia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaEssentia's current Days Inventory of 209.73 is 27.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PharmaEssentia and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaEssentia's current Days Inventory is 209.73, which is 64% below median its own 10-year median of 584.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
PharmaEssentia (FRA:8Z1) has a current Days Inventory of 209.73. The stock's GF Value™ is €14.98, compared to a current price of €15.50 — trading 3.5% above its estimated fair value. The current Days Inventory is 209.73, which is 64% below median its 10-year median of 584.85 and 27.5% above the Drug Manufacturers industry median of 164.48. PharmaEssentia's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For PharmaEssentia (FRA:8Z1), the current Days Inventory is 209.73 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PharmaEssentia (FRA:8Z1) Overvalued in 2026?
Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued.
The current stock price of €15.50 is trading 3.5% above its estimated GF Value™ of €14.98.
Key valuation signals for FRA:8Z1:
Days Inventory: 209.73 (64% below median its 10-year median of 584.85)
GF Value™: €14.98 vs. price of €15.50 (3.5% above fair value)
Industry Position: 27.5% above the Drug Manufacturers median (#733 of 919)
No single metric tells the full story. See the FRA:8Z1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
82GF Score
Get the complete analysis for FRA:8Z1
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8Z1 has been successfully added to your 
